
Clinical Investment Insider by Health Board Advisors ยท 2026-06-24 ยท 15 min
In this episode of Clinical Investment Insider, ๐๐ฅ๐๐ฑ ๐ ๐๐ข๐ซ shares how MedStartr evaluates healthcare companies using the following: ๐๐ณ๐ฐ๐ธ๐ฅ ๐ท๐ข๐ญ๐ช๐ฅ๐ข๐ต๐ช๐ฐ๐ฏ ๐๐ญ๐ช๐ฏ๐ช๐ค๐ช๐ข๐ฏ ๐ง๐ฆ๐ฆ๐ฅ๐ฃ๐ข๐ค๐ฌ ๐๐ข๐ต๐ช๐ฆ๐ฏ๐ต ๐ช๐ฏ๐ด๐ช๐จ๐ฉ๐ต๐ด ๐๐ฐ๐ด๐ฑ๐ช๐ต๐ข๐ญ ๐ฆ๐ฏ๐จ๐ข๐จ๐ฆ๐ฎ๐ฆ๐ฏ๐ต ๐๐ฏ๐ฅ ๐๐-๐ด๐ถ๐ฑ๐ฑ๐ฐ๐ณ๐ต๐ฆ๐ฅ ๐ข๐ฏ๐ข๐ญ๐บ๐ด๐ช๐ด. To identify companies with the highest chance of success. But the conversation goes beyond algorithms. Alex explains why resilience, ethics, and a founder's commitment to solving real healthcare problems Often matter more than any spreadsheet or pitch deck. If you're a healthcare founder, clinician, operator, advisor, or investor This episode offers a practical look at how experienced healthcare investors separate promising ideas from companies that can truly scale.